Skip to main content
MCKMcKesson CorporationSell5.2·$858.90+2.40%

McKesson (MCK) Q2 2026 earnings — TrendMatrix coverage

BEAT+4.1% vs estimateEPS $9.93 vs $9.54 estCurrent verdict Sell 5.2/10

Reported

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure

Event detail · Q2 2026

Key numbers

Reported EPS
$9.93
Estimate
$9.54
Surprise
+4.1%
Revenue (period 2026-06-30)
$105.38B
Score today
5.2/10

Revenue source: xbrl.

Report record · Q2 2026

How the report landed

McKesson (MCK) beat the $9.54 estimate with diluted EPS of $9.93 — a clear 4.1% upside surprise.

Current read · as of 2026-08-23

Where TrendMatrix's rating stands now

TrendMatrix currently rates MCK Sell at 5.2/10; no pre/post engine snapshot brackets this report.

4 of the last 4 quarters beat the estimate; this quarter's +4.1% surprise compares with a +3.7% four-quarter average. Next scheduled report: 2026-11-04.

What argues against it

  • Quality below floor (3.5 < 4.0)
  • Value-trap signals (2/5): Margin compression (op margin -15.5%), Negative free cash flow
  • Reward/Risk 0.5:1 at current price — below 1.5:1 minimum

This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.

Current engine read

The levels TrendMatrix's engine tracks

Current price
$858.90
Price target
$888.24
Stop
$800.48
Upside to target
+3.4%
Reward-to-risk
0.5:1

The stock trades at 22.5× trailing but 17.0× forward earnings — consensus estimates already build in a substantial earnings recovery.

Risk check: trading volume is running 1.5× its average — elevated turnover around the report window.

Model outputs from TrendMatrix’s engine as of 2026-08-23 — shown for context, not personalized investment advice.

Healthcare context

MCK at TrendMatrix's latest read

Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.

Industry
Medical Distribution
Market cap
$100.14B
P/E (fwd)
17.0
P/E (ttm)
22.5
52-week range
$673.38$999.00
Off 52-week high
14.0%
RSI (14)
57
Volume vs avg
1.51×
Score today
5.2/10

Earnings figures are sourced from TrendMatrix’s pipeline (EPS: existing earnings extraction; revenue: SEC XBRL company facts where available, yfinance-provisional otherwise). Not a buy/sell rating, a price target, or investment advice — see the current verdict on the stock’s main page for TrendMatrix’s live read.

Home Stocks MCK Earnings Q2 2026 earnings